The first Canadian experience with the Afirma® gene expression classifier test

The first Canadian experience with the Afirma® gene expression classifier test

Abstract Background Thyroid nodules are common and often benign, although prove to be malignant upon surgical pathology in 5–15% of cases. When assessed with ultrasound-guided fine-needle aspiration (USFNA), 15–30% of the nodules yield an indeterminate result. The Afirma® gene expression classifier...

Full description

Saved in:
Bibliographic Details
Main Authors: Emily Kay-Rivest, Jamie Tibbo, Sarah Bouhabel, Michael Tamilia, Rebecca Leboeuf, Veronique-Isabelle Forest, Michael P. Hier, Loren Savoury, Richard J. Payne
Format: Article
Language:English
Published: SAGE Publishing 2017-04-01
Series:Journal of Otolaryngology - Head and Neck Surgery
Subjects:
Indeterminate thyroid nodules
Molecular testing
Thyroid cancer
Afirma® Gene Expression Classifier
Ultrasound-guided fine-needle aspiration
Online Access:http://link.springer.com/article/10.1186/s40463-017-0201-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://link.springer.com/article/10.1186/s40463-017-0201-7

Similar Items